Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Carcinoma, Hepatocellular 25Carcinoma, Non-Small-Cell Lung 22Small Cell Lung Carcinoma 14Lung Neoplasms 14Neoplasms 11Breast Neoplasms 8Squamous Cell Carcinoma of Head and Neck 6Carcinoma, Renal Cell 6Uterine Cervical Neoplasms 5Melanoma 5Carcinoma, Transitional Cell 5Urinary Bladder Neoplasms 4Triple Negative Breast Neoplasms 4Neoplasm Metastasis 4Colorectal Neoplasms 4Stomach Neoplasms 3Solid Tumors 3Sarcoma, Alveolar Soft Part 3Sarcoma 3Liver Neoplasms 3Glioblastoma 3Extensive Stage Lung Small Cell Carcinoma 3Treatment-Refractory Solid Tumors 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Nasopharyngeal Carcinoma 2Mesothelioma, Malignant 2Lymphoma, Non-Hodgkin 2Esophageal Neoplasms 2

Interventions

Magnetic Resonance Spectroscopy 56enzalutamide 44Specimen Handling 37apalutamide 35Androgen Antagonists 35Abiraterone Acetate 29Prednisone 27Radiosurgery 26darolutamide 25Docetaxel 23Pluvicto 22abiraterone 21Radiotherapy 21Leuprolide 20Biopsy 16relugolix 14acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 14gallium 68 PSMA-11 12Triptorelin Pamoate 12Surveys and Questionnaires 12Radiation 12Gonadotropin-Releasing Hormone 12X-Rays 112-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 10cabazitaxel 9bicalutamide 9Standard of Care 9Nivolumab 9Goserelin 9Carboplatin 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Prostatic Neoplasms × atezolizumab × 90 days × Clear all
NCT05168618 2026-05-14

AtezoCab

University of Utah

Phase 2 Recruiting
33 enrolled
Genitourinary

Prostatic Neoplasms

NCT04262154 2026-05-11

Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
28 enrolled 9 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡